Drug Shortage Report for JAMP-LEVETIRACETAM
Report ID | 151699 |
Drug Identification Number | 02403005 |
Brand name | JAMP-LEVETIRACETAM |
Common or Proper name | Levetiracetam Tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | LEVETIRACETAM |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 120 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-12-03 |
Estimated end date | 2022-04-01 |
Actual end date | 2022-03-25 |
Shortage status | Resolved |
Updated date | 2022-04-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-04-06 | French | Compare |
v7 | 2022-04-06 | English | Compare |
v6 | 2022-03-08 | French | Compare |
v5 | 2022-03-08 | English | Compare |
v4 | 2022-02-14 | French | Compare |
v3 | 2022-02-14 | English | Compare |
v2 | 2021-12-21 | French | Compare |
v1 | 2021-12-21 | English | Compare |
Showing 1 to 8 of 8